| My Eye Dr. | |
|
4465 Willard Ave, Chevy Chase, MD 20815-3605 | |
| (301) 951-3373 | |
| (301) 951-3371 |
| Full Name | My Eye Dr. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 4465 Willard Ave, Chevy Chase, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588729719 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TA0609 (Maryland) | Primary |
| Provider Name | Arnold Miller |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1336182088 PECOS PAC ID: 8628029022 Enrollment ID: I20050208001039 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Vincent A Bertomeu |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1003074139 PECOS PAC ID: 2961436209 Enrollment ID: I20050926000517 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Ross Jay Shoter |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1528001278 PECOS PAC ID: 7214039940 Enrollment ID: I20070226000733 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Pam Bae-li |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1538214838 PECOS PAC ID: 8921173741 Enrollment ID: I20080813000549 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Bruce Goodman |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1730122409 PECOS PAC ID: 7315092160 Enrollment ID: I20090901000199 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Julian M Levy |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1578647715 PECOS PAC ID: 4688706104 Enrollment ID: I20110323000758 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Renu Mathew |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1831112911 PECOS PAC ID: 3375626369 Enrollment ID: I20120504000023 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Calvin Osterman |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1558339739 PECOS PAC ID: 5395890057 Enrollment ID: I20120914000672 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Sepideh Zarani |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1235418583 PECOS PAC ID: 6406026400 Enrollment ID: I20130606000161 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Kevin Mathes |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1831477488 PECOS PAC ID: 9032381876 Enrollment ID: I20130917000043 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Steven Abraham |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1972943173 PECOS PAC ID: 9032349964 Enrollment ID: I20140220000890 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Michael Chait |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1184665341 PECOS PAC ID: 0749241099 Enrollment ID: I20140723001741 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Daniel L Thomas |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1962816421 PECOS PAC ID: 8325269608 Enrollment ID: I20141030001067 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Jasleen K Bedi |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1194843771 PECOS PAC ID: 4284958760 Enrollment ID: I20150112001707 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Jennifer Candelaria Lee |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1255715082 PECOS PAC ID: 0042526055 Enrollment ID: I20150904000604 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Judith Spirer |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1164549515 PECOS PAC ID: 8628384625 Enrollment ID: I20150908001055 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Enrique Gonzalez-bernard |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1871750133 PECOS PAC ID: 1759687825 Enrollment ID: I20160316000362 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Amy Qing Hu |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1467711242 PECOS PAC ID: 9133356256 Enrollment ID: I20170307000597 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Terry B Kim |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1265961627 PECOS PAC ID: 0840563367 Enrollment ID: I20170906000161 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Onyekachukwu A Illoh |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1629504535 PECOS PAC ID: 6204102031 Enrollment ID: I20171024000889 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Dhara Shailesh Shah |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1972056703 PECOS PAC ID: 0941568521 Enrollment ID: I20180103002986 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Kristo Bolano |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1891280020 PECOS PAC ID: 2860741378 Enrollment ID: I20180816001781 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Mandana Nasiri Manesh |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1861050650 PECOS PAC ID: 4587996012 Enrollment ID: I20191101000574 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Azim Raja |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1124654710 PECOS PAC ID: 3577985431 Enrollment ID: I20200623000254 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Tan Kim Duong |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1396351490 PECOS PAC ID: 5496159527 Enrollment ID: I20210811001131 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Misbah Shafiq |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1821670183 PECOS PAC ID: 9931506581 Enrollment ID: I20230417001247 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Lynette Delina Wray |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1033841663 PECOS PAC ID: 2961866801 Enrollment ID: I20230912001000 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Provider Name | Obinna Odozor |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1518647049 PECOS PAC ID: 3072968270 Enrollment ID: I20231009000181 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| My Eye Dr. 8614 Westwood Center Dr Fl 9, Vienna, VA 22182-2442 Ph: (703) 847-8899 | My Eye Dr. 4465 Willard Ave, Chevy Chase, MD 20815-3605 Ph: (301) 951-3373 |
News Archive
CAS Medical Systems, Inc. today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded labeling of its FORE-SIGHT® Absolute Tissue Oximeter to monitor skeletal muscle of infants, children and adolescents weighing between 5 and 50 kg.
Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.
The Biomedical Advanced Research and Development Authority in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure. If the contract is exercised with options, it could total $22.84 million.
"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.
Countries with a skewed sex ratio at birth, because of a cultural preference for sons, are set to ‘lose' another 4.7 million girls by 2030 despite a projected fall in excess male births in these countries over the next 20 years, suggests research published in the online journal BMJ Global Health.
› Verified 4 days ago
Lynette Delina Wray, Optometrist Medicare: Medicare Enrolled Practice Location: 4465 Willard Ave, Chevy Chase, MD 20815 Phone: 301-951-3373 Fax: 301-951-3371 | |
Eye Rx Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 4600 N Park Ave, Plaza North, Chevy Chase, MD 20815 Phone: 301-841-6776 Fax: 301-215-4144 | |
Dr. Amanda Rae Zeller Manley, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6900 Wisconsin Ave, Suite 600, Chevy Chase, MD 20815 Phone: 301-951-0320 Fax: 301-951-0370 | |
Dr. Mehrnaz Dehghan Azimi Green, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 6900 Wisconsin Ave, Ste. 600, Chevy Chase, MD 20815 Phone: 301-951-0320 Fax: 301-951-0370 | |
Azim Hafeez Raja, Optometrist Medicare: May Accept Medicare Assignments Practice Location: 4465 Willard Ave, Chevy Chase, MD 20815 Phone: 301-951-3373 | |
Tamara Mendez Romero, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8401 Connecticut Ave Ste 102, Chevy Chase, MD 20815 Phone: 301-242-3927 | |
Ashley Z Wong, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 4600 N Park Ave, Chevy Chase, MD 20815 Phone: 301-215-7100 Fax: 240-482-1201 |